Sylvester Comprehensive Cancer Center Study Advocates for Targeted Maternal Screening to Prevent Fatal Viral Leukemia

Sylvester study shows maternal HTLV-1 screening could stop adult T-cell leukemia before it starts, especially for high-risk Caribbean-born U.S. residents.

By: AXL Media

Published: May 1, 2026, 10:49 AM EDT

Source: Information for this report was sourced from EurekAlert!

Interrupting the Generational Transmission of Viral Cancer

The fight against adult T-cell leukemia/lymphoma, or ATLL, may find its most effective weapon not in new chemotherapy agents, but in prenatal screening protocols. According to research led by Paulo Pinheiro at the Sylvester Comprehensive Cancer Center, this aggressive and often fatal malignancy is driven by the human T-cell leukemia virus type 1, which is frequently passed from mother to child through breastfeeding. By identifying the presence of this retrovirus decades before cancer develops, medical professionals have a unique opportunity to intervene and prevent the onset of the disease entirely through targeted maternal care.

The Geographic Footprint of ATLL in the United States

Using a comprehensive dataset spanning all 50 U.S. states, the study uncovered a stark disparity in cancer incidence based on a patient's place of birth. While the disease remains rare in the general population, non-Hispanic Caribbean-born residents exhibit a risk level more than 30 times that of individuals born in the United States or Canada. The data points specifically to Florida and New York as primary hubs for the disease, owing to their large populations of residents from endemic regions. This finding shifts the focus from broad racial categories to specific geographic origins, suggesting that birthplace is a primary factor in determining cancer risk.

A Proven Model for Eradication in Endemic Regions

The proposal for maternal screening in the United States is not without precedent, as Japan implemented similar nationwide programs decades ago with significant success. By screening pregnant women and providing counseling on breastfeeding, Japan managed to drastically reduce mother-to-child transmission rates. Currently, the United States only screens blood donors for HTLV-1, leaving a significant diagnostic gap in prenatal care. Implementing a targeted screening program for women from high-risk regions could replicate the international success seen in reducing the long-term burden of this specific leukemia.